002166 莱茵生物
已收盘 05-19 15:00:00
资讯
新帖
简况
股市必读：莱茵生物（002166）5月19日董秘有最新回复
证券之星 · 03:57
股市必读：莱茵生物（002166）5月19日董秘有最新回复
莱茵生物：公司利川提取工厂生产运营状态正常
证券之星 · 05-19 15:27
莱茵生物：公司利川提取工厂生产运营状态正常
莱茵生物：公司与德福资本合作事宜正在积极推进中
证券之星 · 05-19 15:27
莱茵生物：公司与德福资本合作事宜正在积极推进中
莱茵生物：甜菊糖苷RM2国内食品添加剂新品种认证申报目前处于审评中
证券之星 · 05-18 11:42
莱茵生物：甜菊糖苷RM2国内食品添加剂新品种认证申报目前处于审评中
莱茵生物：公司依规严格履行信息披露义务
证券之星 · 05-18 11:36
莱茵生物：公司依规严格履行信息披露义务
莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中
证券之星 · 05-18 11:33
莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中
莱茵生物：现阶段公司各工厂生产进度、运营节奏符合公司规划安排
证券之星 · 05-18 11:33
莱茵生物：现阶段公司各工厂生产进度、运营节奏符合公司规划安排
莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中
证券之星 · 05-15
莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中
莱茵生物：天然甜味剂精准契合无糖、低糖的消费升级方向
证券之星 · 05-15
莱茵生物：天然甜味剂精准契合无糖、低糖的消费升级方向
莱茵生物：关于未来实控人具体的资源赋能、业务合作及引介整合等相关事项
证券之星 · 05-15
莱茵生物：关于未来实控人具体的资源赋能、业务合作及引介整合等相关事项
股市必读：莱茵生物（002166）5月7日董秘有最新回复
证券之星 · 05-08
股市必读：莱茵生物（002166）5月7日董秘有最新回复
莱茵生物：麦角硫因是公司储备的产品之一
证券之星 · 05-07
莱茵生物：麦角硫因是公司储备的产品之一
股市必读：莱茵生物一季报 - 第一季度单季净利润同比增长38.06%
证券之星 · 05-06
股市必读：莱茵生物一季报 - 第一季度单季净利润同比增长38.06%
每周股票复盘：莱茵生物（002166）Q1净利增38.06%
证券之星 · 05-03
每周股票复盘：莱茵生物（002166）Q1净利增38.06%
图解莱茵生物一季报：第一季度单季净利润同比增长38.06%
证券之星 · 04-30
图解莱茵生物一季报：第一季度单季净利润同比增长38.06%
莱茵生物（002166）披露2025年度股东会决议公告，4月27日股价下跌0.12%
证券之星 · 04-27
莱茵生物（002166）披露2025年度股东会决议公告，4月27日股价下跌0.12%
莱茵生物：公司主营天然健康功能性成分的研发与生产
证券之星 · 04-21
莱茵生物：公司主营天然健康功能性成分的研发与生产
莱茵生物（002166）披露股东部分股份解除质押公告，4月20日股价上涨0.22%
证券之星 · 04-20
莱茵生物（002166）披露股东部分股份解除质押公告，4月20日股价上涨0.22%
莱茵生物（002166）披露2025年度网上业绩说明会安排，4月07日股价上涨1.0%
证券之星 · 04-07
莱茵生物（002166）披露2025年度网上业绩说明会安排，4月07日股价上涨1.0%
图解莱茵生物年报：第四季度单季净利润同比增长18.48%
证券之星 · 03-31
图解莱茵生物年报：第四季度单季净利润同比增长18.48%
加载更多
公司概况
公司名称：
桂林莱茵生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2007-09-13
主营业务：
桂林莱茵生物科技股份有限公司的主营业务是植物功能性成分的研发与生产。公司的主要产品是罗汉果提取物、甜叶菊提取物、茶叶提取物及其他植物提取物，瑞鲍迪苷RM2及甜菊糖苷RM系列产品、左旋β-半乳葡聚糖等。
发行价格：
9.89
{"stockData":{"symbol":"002166","market":"SZ","secType":"STK","nameCN":"莱茵生物","latestPrice":8.82,"timestamp":1779174204000,"preClose":8.72,"halted":0,"volume":7853456,"delay":0,"changeRate":0.0115,"floatShares":739000000,"shares":742000000,"eps":0.2088,"marketStatus":"已收盘","change":0.1,"latestTime":"05-19 15:00:00","open":8.69,"high":8.9,"low":8.69,"amount":68979000,"amplitude":0.0241,"askPrice":8.82,"askSize":443,"bidPrice":8.81,"bidSize":88,"shortable":0,"etf":0,"ttmEps":0.2088,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779240600000},"marketStatusCode":5,"adr":0,"adjPreClose":8.72,"symbolType":"stock","openAndCloseTimeList":[[1779154200000,1779161400000],[1779166800000,1779174000000]],"highLimit":9.59,"lowLimit":7.85,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":741609425,"isCdr":false,"pbRate":2.03,"roa":"--","peRate":42.241379,"roe":"1.34%","epsLYR":0.1945,"committee":-0.45666,"marketValue":6541000000,"turnoverRate":0.0106,"status":0,"floatMarketCap":6514000000},"requestUrl":"/m/hq/s/002166/","defaultTab":"news","newsList":[{"id":"2636611368","title":"股市必读：莱茵生物（002166）5月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636611368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636611368?lang=zh_cn&edition=full","pubTime":"2026-05-20 03:57","pubTimestamp":1779220628,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，莱茵生物报收于8.82元，上涨1.15%，换手率1.06%，成交量7.85万手，成交额6897.9万元。董秘最新回复投资者： 德福资本合作进度是否在等某种条件，比如RM2获批作为条件董秘： 您好，公司与德福资本合作事宜正在积极推进中，不存在您提及的这种情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000004972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0168","BK0174","002166","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636383341","title":"莱茵生物：公司利川提取工厂生产运营状态正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2636383341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636383341?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:27","pubTimestamp":1779175630,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：利川项目还有生产吗，主要产品是什么，多大产量莱茵生物回复：您好，公司利川提取工厂生产运营状态正常，主营产品为茶提取物，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900021987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0028","BK0046","BK0168","002166","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636783311","title":"莱茵生物：公司与德福资本合作事宜正在积极推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2636783311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636783311?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:27","pubTimestamp":1779175629,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：德福资本合作进度是否在等某种条件，比如RM2获批作为条件莱茵生物回复：您好，公司与德福资本合作事宜正在积极推进中，不存在您提及的这种情形。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900021985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0046","002166","BK0239","BK0028","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636904694","title":"莱茵生物：甜菊糖苷RM2国内食品添加剂新品种认证申报目前处于审评中","url":"https://stock-news.laohu8.com/highlight/detail?id=2636904694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636904694?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:42","pubTimestamp":1779075725,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物05月18日在投资者关系平台上答复投资者关心的问题。公司甜菊糖苷RM2国内食品添加剂新品种认证申报目前处于审评中，最终能否获批以及拿证周期尚存在不确定性，敬请投资者注意投资风险。目前，公司甜菊糖苷RM2已取得FDA GRAS认证，具备海外合规销售资质，相关产能设施也已布局完备，后续公司将稳步推进海外市场拓展，逐步释放合成生物车间产能，推动业务稳健发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800013142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0174","159151","BK0046","BK0028","002166","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636046589","title":"莱茵生物：公司依规严格履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2636046589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636046589?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:36","pubTimestamp":1779075376,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物05月18日在投资者关系平台上答复投资者关心的问题。在控制权变更、发行股份购买资产及募集配套资金项目上，公司依规严格履行信息披露义务，不存在应披露而未披露的事项，敬请各位投资者理性投资，注意投资风险，谢谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800012765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0239","BK0028","002166","BK0046","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636463300","title":"莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中","url":"https://stock-news.laohu8.com/highlight/detail?id=2636463300","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636463300?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:33","pubTimestamp":1779075219,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：公司控制权变更和金康普股权收购事项已过去5个月，目前审批进展如何？是否遇到障碍？何时能完成交割？如果延期，原因是什么？莱茵生物回复：您好，公司股份协议转让及发行股份购买资产等交易，处于积极推进当中，项目最终能否按照预期实现落地，存在一定的不确定性，请投资者注意投资风险。公司将严格按照相关法律法规要求及时披露项目进展情况，敬请投资者及时关注公司公告。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800012588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0046","BK0028","BK0239","002166","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636046354","title":"莱茵生物：现阶段公司各工厂生产进度、运营节奏符合公司规划安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2636046354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636046354?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:33","pubTimestamp":1779075218,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：甜叶菊新工厂投产已一段时间，现实际产能利用率多少？是否达到预期？美国工厂运营状况和盈利情况如何？美国CBD产业政策日益友好，公司业务拓展增量多少？谢谢莱茵生物回复：感谢您的关注。现阶段公司各工厂生产进度、运营节奏符合公司规划安排，整体业务经营平稳有序。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800012587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002166","BK0046","BK0239","BK0168","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635720214","title":"莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中","url":"https://stock-news.laohu8.com/highlight/detail?id=2635720214","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635720214?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:40","pubTimestamp":1778805622,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问定增并购的标的公司审计为什么迟迟有结果？有什么困难？未来实控人是不是提高一下效率？莱茵生物回复：您好，公司股份协议转让及发行股份购买资产等交易，处于积极推进当中，项目最终能否按照预期实现落地，存在一定的不确定性，请投资者注意投资风险。公司将严格按照相关法律法规要求及时披露项目进展情况，敬请投资者及时关注公司公告。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500009006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002166","BK0046","BK0239","BK0168","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635202367","title":"莱茵生物：天然甜味剂精准契合无糖、低糖的消费升级方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202367?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:40","pubTimestamp":1778805622,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物05月14日在投资者关系平台上答复投资者关心的问题。如行业头部品牌率先应用天然甜味剂复配方案，会起到较好的行业示范效应，从而带动更多食饮品牌跟进，拉动甜菊糖苷、罗汉果甜苷的市场采购需求放量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500009004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0174","BK0028","002166","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635202267","title":"莱茵生物：关于未来实控人具体的资源赋能、业务合作及引介整合等相关事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2635202267","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635202267?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:40","pubTimestamp":1778805622,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物05月14日在投资者关系平台上答复投资者关心的问题。是不是考虑和公司将来的实控人先建立战略合作关系，具体在某几个方面先行进行赋能。关于未来实控人具体的资源赋能、业务合作及引介整合等相关事项，若后续有明确进展及相关安排，公司将严格按照相关法律法规要求及时履行信息披露义务，感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500009005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0239","002166","BK0174","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633175471","title":"股市必读：莱茵生物（002166）5月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2633175471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633175471?lang=zh_cn&edition=full","pubTime":"2026-05-08 03:56","pubTimestamp":1778183770,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，莱茵生物报收于8.9元，下跌0.11%，换手率1.37%，成交量10.15万手，成交额9063.29万元。董秘最新回复投资者： 尊敬董秘，你好！最近“长寿维生素”麦角硫因被列新食品材料，请问公司是否有该项目合成工艺？交易信息汇总资金流向5月7日主力资金净流出252.35万元；游资资金净流入835.02万元；散户资金净流出582.66万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800003849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0174","BK0239","BK0168","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633163801","title":"莱茵生物：麦角硫因是公司储备的产品之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2633163801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633163801?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:33","pubTimestamp":1778142791,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬董秘，你好！最近“长寿维生素”麦角硫因被列新食品材料，请问公司是否有该项目合成工艺？是否有投资意向？莱茵生物回复：您好，麦角硫因是公司储备的产品之一。目前公司正在推进该产品的合成生物工艺技术的开发和验证工作，能否推向市场尚存在不确定性，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700026697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0168","BK0028","002166","BK0239","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633786999","title":"股市必读：莱茵生物一季报 - 第一季度单季净利润同比增长38.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633786999","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633786999?lang=zh_cn&edition=full","pubTime":"2026-05-06 06:23","pubTimestamp":1778019789,"startTime":"0","endTime":"0","summary":"来自业绩披露要点：莱茵生物2026年一季度归母净利润为4251.65万元，同比增长38.06%。股本股东变化股东户数变动近日莱茵生物披露，截至2026年3月31日公司股东户数为3.9万户，较2月28日减少1649.0户，减幅为4.05%。业绩披露要点财务报告莱茵生物2026年一季报显示，一季度公司主营收入4.47亿元，同比上升0.58%；归母净利润4251.65万元，同比上升38.06%；扣非净利润4032.82万元，同比上升11.6%；负债率36.17%，投资收益5.27万元，财务费用1367.88万元，毛利率23.72%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600004270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632967074","title":"每周股票复盘：莱茵生物（002166）Q1净利增38.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632967074","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632967074?lang=zh_cn&edition=full","pubTime":"2026-05-03 07:37","pubTimestamp":1777765030,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，莱茵生物报收于8.78元，较上周的8.65元上涨1.5%。本周，莱茵生物4月30日盘中最高价报8.8元。本周关注点来自业绩披露要点：莱茵生物2026年一季度归母净利润同比增长38.06%。股本股东变化股东户数变动截至2026年3月31日，莱茵生物股东户数为3.9万户，较2月28日减少1649.0户，减幅为4.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0174","BK0239","BK0168","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631528985","title":"图解莱茵生物一季报：第一季度单季净利润同比增长38.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631528985","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631528985?lang=zh_cn&edition=full","pubTime":"2026-04-30 03:09","pubTimestamp":1777489790,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物2026年一季报显示，一季度公司主营收入4.47亿元，同比上升0.58%；归母净利润4251.65万元，同比上升38.06%；扣非净利润4032.82万元，同比上升11.6%；负债率36.17%，投资收益5.27万元，财务费用1367.88万元，毛利率23.72%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000008888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630360121","title":"莱茵生物（002166）披露2025年度股东会决议公告，4月27日股价下跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630360121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630360121?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:44","pubTimestamp":1777286640,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘，莱茵生物报收于8.64元，较前一交易日下跌0.12%，最新总市值为64.08亿元。该股当日开盘8.58元，最高8.67元，最低8.48元，成交额达7310.6万元，换手率为1.16%。公司于近日披露《2025年度股东会决议公告》。会议采取现场投票与网络投票相结合的方式进行，表决结果均为通过，无否决提案情形。北京德恒律师事务所对本次会议出具法律意见，认为会议召集、召开程序及表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700035270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0174","002166","BK0168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629088987","title":"莱茵生物：公司主营天然健康功能性成分的研发与生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2629088987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629088987?lang=zh_cn&edition=full","pubTime":"2026-04-21 15:03","pubTimestamp":1776754995,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物04月21日在投资者关系平台上答复投资者关心的问题。非常感谢您对公司的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100029294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0174","BK0028","BK0239","BK0168","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628874958","title":"莱茵生物（002166）披露股东部分股份解除质押公告，4月20日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628874958","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628874958?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:47","pubTimestamp":1776678468,"startTime":"0","endTime":"0","summary":"莱茵生物于2026年4月20日发布公告称，公司大股东秦本军先生已于2026年4月16日向国海证券股份有限公司偿还全部融资借款，并办理了部分股份解除质押手续。本次解除质押股份2,640.00万股，占其所持公司股份比例9.73%，占公司总股本比例3.56%。截至公告披露日，秦本军先生累计持有公司股份27,138.96万股，持股比例36.59%，累计质押股份7,830.00万股，占其所持股份比例28.85%，占公司总股本比例10.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000025046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","002166","BK0046","BK0239","BK0028","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625599939","title":"莱茵生物（002166）披露2025年度网上业绩说明会安排，4月07日股价上涨1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625599939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625599939?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:34","pubTimestamp":1775554458,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，莱茵生物报收于9.13元，较前一交易日上涨1.0%，最新总市值为67.71亿元。近日，莱茵生物披露《关于举办2025年度网上业绩说明会的公告》。公告显示，公司已于2026年3月31日在巨潮资讯网披露2025年年度报告。为便于投资者了解公司经营、财务及发展战略情况，公司将于2026年4月9日15:00-16:00通过价值在线平台举行2025年度网上业绩说明会，采用网络文字互动方式与投资者交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0168","BK0046","BK0174","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623328009","title":"图解莱茵生物年报：第四季度单季净利润同比增长18.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623328009","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623328009?lang=zh_cn&edition=full","pubTime":"2026-03-31 01:52","pubTimestamp":1774893168,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物2025年年报显示，当年度公司主营收入20.44亿元，同比上升15.36%；归母净利润1.43亿元，同比下降12.2%；扣非净利润1.27亿元，同比下降16.32%；其中2025年第四季度，公司单季度主营收入7.72亿元，同比上升28.23%；单季度归母净利润7272.94万元，同比上升18.48%；单季度扣非净利润6519.64万元，同比上升39.21%；负债率39.8%，投资收益460.05万元，财务费用4384.09万元，毛利率25.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033100004589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779225595265,"stockEarnings":[{"period":"1week","weight":-0.0297},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0096},{"period":"6month","weight":0.1061},{"period":"1year","weight":0.1924},{"period":"ytd","weight":0.055}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0292},{"period":"3month","weight":0.0214},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.2381},{"period":"ytd","weight":0.0506}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"桂林莱茵生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"39042人(较上一季度减少4.05%)","perCapita":"18917股","listingDate":"2007-09-13","address":"广西壮族自治区桂林市临桂区人民南路19号","registeredCapital":"74160万元","survey":" 桂林莱茵生物科技股份有限公司的主营业务是植物功能性成分的研发与生产。公司的主要产品是罗汉果提取物、甜叶菊提取物、茶叶提取物及其他植物提取物，瑞鲍迪苷RM2及甜菊糖苷RM系列产品、左旋β-半乳葡聚糖等。","listedPrice":9.89},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱茵生物,002166,莱茵生物股票,莱茵生物股票老虎,莱茵生物股票老虎国际,莱茵生物行情,莱茵生物股票行情,莱茵生物股价,莱茵生物股市,莱茵生物股票价格,莱茵生物股票交易,莱茵生物股票购买,莱茵生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}